TrialHIV clinical trials

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.

Lisa M Demeter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.